Simulations Plus Ebitda Over Time
| SLP Stock | USD 31.72 1.02 3.12% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Simulations Plus Performance and Simulations Plus Correlation. Simulations |
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Simulations Plus. If investors know Simulations will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Simulations Plus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.48 | Dividend Share 0.24 | Earnings Share 0.49 | Revenue Per Share 3.503 | Quarterly Revenue Growth 0.194 |
The market value of Simulations Plus is measured differently than its book value, which is the value of Simulations that is recorded on the company's balance sheet. Investors also form their own opinion of Simulations Plus' value that differs from its market value or its book value, called intrinsic value, which is Simulations Plus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Simulations Plus' market value can be influenced by many factors that don't directly affect Simulations Plus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Simulations Plus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Simulations Plus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Simulations Plus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Ebitda Analysis
Compare Simulations Plus and related stocks such as Definitive Healthcare, National Research Corp, and Evolent Health Ebitda Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DH | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 44.9 M | 23.1 M | 23.4 M | (241.2 M) | (229.2 M) |
| NRC | 561 K | 23.8 M | 27.4 M | 28.6 M | 32.2 M | 31.7 M | 35.8 M | 39 M | 41.7 M | 48.1 M | 50.8 M | 56.7 M | 51.8 M | 46 M | 23.3 M |
| EVH | (19.5 M) | (19.5 M) | (19.5 M) | (66.2 M) | (25.2 M) | (449.9 M) | 96.8 M | (40 M) | (8.3 M) | (65.5 M) | (241.4 M) | 55.7 M | 43.7 M | (24.8 M) | (26 M) |
| PRVA | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 17.5 M | 27.2 M | (215 M) | (14.6 M) | 27.2 M | 28.5 M |
| HSTM | (4.1 M) | 16.8 M | 20.1 M | 22.5 M | 27.3 M | 30.6 M | 27.8 M | 36.1 M | 39.7 M | 42.6 M | 46 M | 44.9 M | 50.4 M | 59.6 M | 62.6 M |
| FORA | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (1.3 M) | (5 M) | (24 M) | (18.3 M) | 2.8 M | 2.9 M |
| HQY | 10.3 M | 10.3 M | 10.3 M | 15.7 M | 18.1 M | 34.7 M | 54.4 M | 70.4 M | 95.9 M | 155.4 M | 154.9 M | 103 M | 171.5 M | 282.4 M | 296.5 M |
| HCAT | (39.6 M) | (39.6 M) | (39.6 M) | (39.6 M) | (39.6 M) | (39.6 M) | (39.6 M) | (39.6 M) | (52.1 M) | (45.7 M) | (79.5 M) | (101.7 M) | (82.9 M) | (66.5 M) | (69.8 M) |
Simulations Plus and related stocks such as Definitive Healthcare, National Research Corp, and Evolent Health Ebitda description
My Equities
My Current Equities and Potential Positions
Additional Tools for Simulations Stock Analysis
When running Simulations Plus' price analysis, check to measure Simulations Plus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Simulations Plus is operating at the current time. Most of Simulations Plus' value examination focuses on studying past and present price action to predict the probability of Simulations Plus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Simulations Plus' price. Additionally, you may evaluate how the addition of Simulations Plus to your portfolios can decrease your overall portfolio volatility.